Sai Life Sciences Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹1272.00
Market cap
26,938 Cr
Stock P/E
69.3
P/B
10.85

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales440 Cr580 Cr496 Cr537 Cr556 Cr602 Cr
Operating expenses (approx.)311 Cr412 Cr366 Cr376 Cr369 Cr410 Cr
EBITDA129 Cr167 Cr131 Cr161 Cr188 Cr192 Cr
OPM %29.3%28.8%26.4%30.0%33.8%31.9%
Other income9 Cr10 Cr10 Cr15 Cr8 Cr16 Cr
Interest23 Cr11 Cr12 Cr9 Cr10 Cr8 Cr
Depreciation34 Cr37 Cr38 Cr40 Cr44 Cr45 Cr
Profit before tax72 Cr119 Cr81 Cr112 Cr134 Cr139 Cr
Tax %24.8%25.7%25.1%25.2%25.2%25.1%
Net profit54 Cr88 Cr60 Cr84 Cr100 Cr104 Cr
EPS (₹)₹2.89₹4.24₹2.90₹4.01₹4.77₹4.93

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2025Mar 2026TTM
Sales1,695 Cr2,192 CrSign in for TTM
Operating expenses (approx.)1,252 Cr1,520 CrSign in for TTM
EBITDA442 Cr672 CrSign in for TTM
OPM %26.1%30.7%Sign in for TTM
Other income37 Cr49 CrSign in for TTM
Interest76 Cr39 CrSign in for TTM
Depreciation139 Cr167 CrSign in for TTM
Profit before tax228 Cr466 CrSign in for TTM
Tax %25.3%25.2%Sign in for TTM
Net profit170 Cr349 CrSign in for TTM
EPS (₹)₹8.83₹16.63Sign in for TTM
Dividend payout %0.0%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025Mar 2026
Equity capital21 Cr21 Cr
Reserves2,108 Cr2,463 Cr
Borrowings129 Cr75 Cr
Other liabilities903 Cr1,068 Cr
Total liabilities3,160 Cr3,626 Cr
Fixed assets (net)1,477 Cr1,809 Cr
CWIP124 Cr270 Cr
Investments2 Cr51 Cr
Other assets1,505 Cr1,411 Cr
Total assets3,160 Cr3,626 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025Mar 2026
Cash from operating activity314 Cr509 Cr
Cash from investing-537 Cr-395 Cr
Cash from financing301 Cr-124 Cr
Net cash flow79 Cr-9 Cr
Free cash flow (OCF − Capex)-55 Cr-84 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2025Mar 2026
ROCE %13.5%19.8%
ROE %8.0%14.0%
Debtor days——
Inventory days9495
Days payable——
Cash conversion cycle9495
Debt / equity0.060.03
Current ratio2.051.69
Net debt / EBITDA0.08-0.01

Compare with peers

Loading peers…